| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000036035 |
| Receipt No. | R000041019 |
| Scientific Title | Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A Scoping Review |
| Date of disclosure of the study information | 2019/02/28 |
| Last modified on | 2020/02/19 (Ver. 2) |
| Basic information | ||
| Public title | Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A Scoping Review | |
| Acronym | Surveillance systems for healthcare-associated infection | |
| Scientific Title | Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A Scoping Review | |
| Scientific Title:Acronym | Surveillance systems for healthcare-associated infection | |
| Region |
|
|
| Condition | ||
| Condition | healthcare-associated infection | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | obtain information concerning national healthcare-associated infection surveillance systems in high and upper-middle income countries by following methods: academic literature search in PubMed, Google search, and questionnaire to the Embassies of Japan |
| Basic objectives2 | Others |
| Basic objectives -Others | assess the accessibility to the systems |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | For each country, the following information is reviewed:name of the system, official website, languages used in the official website, foundation year, operating body (such as the Ministry of Health or its equivalent, academic society, or a research group), type of survey (prevalence or incidence), reporting periodicity, mode of participation (mandatory or voluntary), targeted medical facilities, targeted healthcare-associated infections and definitions, targeted antimicrobial resistant pathogens, parameters (especially denominators) |
| Key secondary outcomes | For each country, online accessibility to the official websites in English is assessed as an availability of the key websites in the top 30 hits and their hit rank on Google search |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | For academic literature review on PubMed
1) discussing about national healthcare-associated infections surveillance systems 2) written in English 3) published in 2011 and thereafter 4) any type of study design 5) any article types except conference abstract |
|||
| Key exclusion criteria | For academic literature review on PubMed
1) articles about healthcare-associated infections surveillance in a single institution 2) articles about occupational exposure of infectious diseases by medical personnel |
|||
| Target sample size | 0 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Center for Global Health and Medicine | ||||||
| Division name | AMR Clinical Reference Center | ||||||
| Zip code | |||||||
| Address | 1-21-1, Toyama, Shinjuku, Tokyo | ||||||
| TEL | 0332027181 | ||||||
| nohmagari@hosp.ncgm.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Center for Global Health and Medicine | ||||||
| Division name | AMR Clinical Reference Center | ||||||
| Zip code | |||||||
| Address | 1-21-1, Toyama, Shinjuku, Tokyo | ||||||
| TEL | 0332027181 | ||||||
| Homepage URL | |||||||
| takayasaho@gmail.com | |||||||
| Sponsor | |
| Institute | National Center for Global Health and Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Center for Global Health and Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | National Center for Global Health and Medicine |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | https://www.sciencedirect.com/science/article/abs/pii/S1341321X20300088 |
| Number of participants that the trial has enrolled | 0 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This scoping review included academic literature search in PubMed, Google search, and questionnaires by the Embassies of Japan
The search terms for PubMed: 1 Cross-Infection [Mesh] 2 Cross-Infection 3 Healthcare-Associated Infection 4 Health-Care Associated Infection 5 Hospital-Acquired Infection 6 Nosocomial Infection 7 1 OR 2 OR 3 OR 4 OR 5 OR 6 8 Epidemiological Monitoring [Mesh] 9 Public Health Surveillance [Mesh] 10 Infection Control/Methods [Mesh] 11 Data Collection/Methods [Mesh] 12 Health Care Surveys/Methods [Mesh] 13 Population Surveillance/Methods [Mesh] 14 10 OR 11 OR 12 OR 13 15 English [Language] 16 2011/01/01 [Date of Publication]: 2017/06/28 [Date of Publication] 17 7 AND 14 AND 15 AND 16 The search terms for Google: (name of each targeted country) AND (healthcare associated infection OR health care associated infection OR hospital acquired infection OR nosocomial infection OR cross infection) AND (national OR nationwide) AND (monitoring OR surveillance OR survey OR data collection) |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041019 |